Skip to content
The Nexus
DossierENTITY

Most Favored Nation policy

Coverage of Most Favored Nation policy in the Nexus archive.

Earliest in view: Apr 23 · 16:59 UTCMost recent: Apr 23 · 16:59 UTC
Co-mentioned in this coverage
Donald Trumpperson1Regeneronorganization1U.S. Department of Health and Human Servicesorganization1Medicaidtopic1TrumpRxorganization1Democratsorganization1pharmaceutical companiestopic1
Recent coverage
  • HEALTHApr 23 · 16:59 UTCAXIOS
    Trump cuts drug price deal with Regeneron

    President Trump announced a drug pricing deal with Regeneron, the 17th pharmaceutical company to agree to his 'most favored nation' policy, lowering prices for Medicaid and cash-paying patients. Critics question the impact of the confidential agreements, as discounts may not affect most Americans on private insurance or Medicare.

Most Favored Nation policy · Dossier · The Nexus